➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Boehringer Ingelheim
Moodys
Express Scripts
Mallinckrodt

Last Updated: June 15, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Puerarin


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Puerarin?

Puerarin is an investigational drug.

There have been 7 clinical trials for Puerarin. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2013.

The most common disease conditions in clinical trials are Arthritis, Rheumatoid, Arthritis, and Collagen Diseases. The leading clinical trial sponsors are Chengdu PLA General Hospital, The University of Hong Kong, and Health and Medical Research Fund, Hong Kong.

There are one hundred and forty-three US patents protecting this investigational drug and eight hundred and forty-seven international patents.

Recent Clinical Trials for Puerarin
TitleSponsorPhase
Pueraria Lobata and Pueraria Thomsonii for Mild DyslipidemiaJiangxi University of Traditional Chinese MedicineN/A
Effect of Puerarin on Heart Health in MenHealth and Medical Research Fund, Hong KongPhase 2
Effect of Puerarin on Heart Health in MenThe University of Hong KongPhase 2

See all Puerarin clinical trials

Clinical Trial Summary for Puerarin

Top disease conditions for Puerarin
Top clinical trial sponsors for Puerarin

See all Puerarin clinical trials

US Patents for Puerarin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Puerarin   Get Started Free Engineered rice having alcoholism relief and liver protection function, and preparation method thereof China National Research Institute of Food and Fermentation Industries Co., Ltd. (Beijing, CN) Perfect (China) Co., Ltd. (Guangdong, CN)   Get Started Free
Puerarin   Get Started Free Multifunctional (meth)acrylate manufacturing method TOAGOSEI CO., LTD. (Tokyo, JP)   Get Started Free
Puerarin   Get Started Free Method for producing (meth)acrylate TOAGOSEI CO., LTD (Tokyo, JP)   Get Started Free
Puerarin   Get Started Free Fire extinguishing composition comprising aldoketones compound XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD. (Xi'An Shaanxi, CN)   Get Started Free
Puerarin   Get Started Free Whitening composition and the use thereof INFINITUS (CHINA) COMPANY LTD (Jiang Men, CN)   Get Started Free
Puerarin   Get Started Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Puerarin

Drugname Country Document Number Estimated Expiration Related US Patent
Puerarin China CN102648751 2032-05-02   Get Started Free
Puerarin Japan JP2015517298 2032-05-02   Get Started Free
Puerarin Japan JP5957600 2032-05-02   Get Started Free
Puerarin World Intellectual Property Organization (WIPO) WO2013163940 2032-05-02   Get Started Free
Puerarin China CN106029628 2034-04-16   Get Started Free
Puerarin European Patent Office EP3133058 2034-04-16   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Johnson and Johnson
AstraZeneca
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.